Orion Infusion Balance Sheet Health
Financial Health criteria checks 2/6
Orion Infusion has a total shareholder equity of BDT295.8M and total debt of BDT325.6M, which brings its debt-to-equity ratio to 110.1%. Its total assets and total liabilities are BDT828.7M and BDT532.9M respectively. Orion Infusion's EBIT is BDT80.7M making its interest coverage ratio 2.8. It has cash and short-term investments of BDT16.3M.
Key information
110.1%
Debt to equity ratio
৳325.55m
Debt
Interest coverage ratio | 2.8x |
Cash | ৳16.25m |
Equity | ৳295.81m |
Total liabilities | ৳532.93m |
Total assets | ৳828.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ORIONINFU's short term assets (BDT433.5M) do not cover its short term liabilities (BDT504.4M).
Long Term Liabilities: ORIONINFU's short term assets (BDT433.5M) exceed its long term liabilities (BDT28.5M).
Debt to Equity History and Analysis
Debt Level: ORIONINFU's net debt to equity ratio (104.6%) is considered high.
Reducing Debt: ORIONINFU's debt to equity ratio has reduced from 121.8% to 110.1% over the past 5 years.
Debt Coverage: ORIONINFU's debt is not well covered by operating cash flow (18.5%).
Interest Coverage: ORIONINFU's interest payments on its debt are not well covered by EBIT (2.8x coverage).